Skip to main content
TipRanks
Go Ultimate75% OFF

Rakovina Therapeutics Inc (RKV) Financial Statements

22 Followers

Rakovina Therapeutics Inc Financial Overview

Rakovina Therapeutics Inc's market cap is currently $4.52M. The company's EPS TTM is ―; its P/E ratio is -0.58; Rakovina Therapeutics Inc has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 23Dec 22Dec 21
Income Statement
Total Revenue―――
Gross Profit―――
Operating Income$ -2.48M$ -2.82M$ -2.47M
EBITDA$ -1.93M$ -2.26M$ -5.11M
Net Income$ -2.61M$ -2.79M$ -5.52M
Balance Sheet
Cash & Short-Term Investments―――
Total Assets$ 5.15M$ 6.12M$ 8.66M
Total Debt$ 1.33M$ 0.00$ 0.00
Net Debt$ 896.78K$ -896.83K$ -2.81M
Total Liabilities$ 1.49M$ 107.05K$ 113.98K
Stockholders' Equity―――
Cash Flow
Free Cash Flow―$ -1.92M$ -2.31M
Operating Cash Flow―――
Investing Cash Flow―――
Financing Cash Flow―――

Currency in USD